• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

    7/16/24 8:15:39 AM ET
    $APLT
    $AVXL
    $CFB
    $DJT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $APLT alert in real time by email

    U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 40 points on Tuesday.

    Shares of CrossFirst Bankshares, Inc. (NASDAQ:CFB) fell sharply in today's pre-market trading following second-quarter results.

    CrossFirst Bankshares reported quarterly earnings of 37 cents per share, according to data from Benzinga Pro.

    CrossFirst Bankshares shares dipped 12.3% to $13.98 in the pre-market trading session.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Applied Therapeutics, Inc. (NASDAQ:APLT) fell 11.8% to $5.24 in pre-market trading after gaining 7% on Monday.
    • Owens & Minor, Inc. (NYSE:OMI) dipped 10.6% to $12.35 in pre-market trading. Baird analyst Eric Coldwell maintained Owens & Minor with a Neutral and lowered the price target from $20 to $19.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) shares declined 8.8% to $37.03 in pre-market trading. Trump Media & Technology Group shares jumped over 31% on Monday following the attempted assassination of Donald Trump.
    • Anavex Life Sciences Corp. (NASDAQ:AVXL) slipped 7% to $5.43 in pre-market trading after surging 8% on Monday.
    • Indivior PLC (NASDAQ:INDV) shares fell 4.1% to $9.98 in pre-market trading following a 4% decline on Monday.
    • Funko, Inc. (NASDAQ:FNKO) shares fell 3.5% to $9.70 in pre-market trading.
    • Reddit, Inc. (NYSE:RDDT) shares declined 3.4% to $70.51 in pre-market trading fter Loop Capital downgraded the stock from Buy to hold.

    Now Read This:

    • Dow Jones Jumps Over 200 Points Amid Improving Investor Sentiment: Fear Index Stays In ‘Greed’ Zone
    Get the next $APLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLT
    $AVXL
    $CFB
    $DJT

    CompanyDatePrice TargetRatingAnalyst
    Reddit Inc.
    $RDDT
    4/7/2026$149.00Equal Weight
    Wells Fargo
    Reddit Inc.
    $RDDT
    2/6/2026$245.00 → $250.00Buy
    B. Riley Securities
    Reddit Inc.
    $RDDT
    1/13/2026$320.00Outperform
    Evercore ISI
    Reddit Inc.
    $RDDT
    1/8/2026$240.00Neutral
    Cantor Fitzgerald
    Applied Therapeutics Inc.
    $APLT
    12/12/2025Outperform → Neutral
    Robert W. Baird
    Reddit Inc.
    $RDDT
    12/9/2025$300.00Buy
    China Renaissance
    Applied Therapeutics Inc.
    $APLT
    12/3/2025$1.00Outperform → Market Perform
    Leerink Partners
    Owens & Minor Inc.
    $OMI
    11/3/2025$4.00Buy → Neutral
    UBS
    More analyst ratings

    $APLT
    $AVXL
    $CFB
    $DJT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

    NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it will present at the 25th Annual Needham Virtual Healthcare Conference, April 13 – 16, 2026. President and Chief Executive Officer Christopher U. Missling, PhD and his management team will present the Company scheduled at 1:30 PM (ET) on Tuesday, April 14th, 2026. A live audio

    4/7/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

    Model estimates SUBLOCADE® may reduce staff time and associated costs compared with other medications for opioid use disorder in jails and prisons RICHMOND, Va., March 31, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc., (NASDAQ:INDV) today announced findings from a new cost impact model published in The Journal of Current Medical Research and Opinion, estimating that the use of extended-release buprenorphine, a monthly injectable commercially available as SUBLOCADE®, may reduce staff time and associated costs in jails and prisons compared with other medications for opioid use disorder (MOUD). "Correctional facilities face ongoing staffing constraints as the need for MOUD conti

    3/31/26 9:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anavex Life Sciences Provides Comprehensive Regulatory Update

    Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral blarcamesine in early Alzheimer's disease Additional data submitted to the U.S. FDA with the objective to discuss potential pathways towards a New Drug Application (NDA) for the treatment of early Alzheimer's disease Additionally, Anavex has engaged in discussions with EU regulators regarding blarcamesine for Parkinson's disease and rare diseases, including Rett syndrome NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's dise

    3/30/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLT
    $AVXL
    $CFB
    $DJT
    SEC Filings

    View All

    SEC Form 425 filed by Trump Media & Technology Group Corp.

    425 - Trump Media & Technology Group Corp. (0001849635) (Subject)

    4/7/26 4:00:24 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Reddit Inc.

    SCHEDULE 13G/A - Reddit, Inc. (0001713445) (Subject)

    4/7/26 2:06:49 PM ET
    $RDDT
    EDP Services
    Technology

    SEC Form 425 filed by Trump Media & Technology Group Corp.

    425 - Trump Media & Technology Group Corp. (0001849635) (Subject)

    3/30/26 5:29:17 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    $APLT
    $AVXL
    $CFB
    $DJT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Sarah E bought $1,388,730 worth of shares (10,500 units at $132.26) (SEC Form 4)

    4 - Reddit, Inc. (0001713445) (Issuer)

    3/17/26 7:20:55 PM ET
    $RDDT
    EDP Services
    Technology

    Director Ryan Barbara bought $249 worth of shares (8 units at $31.09), increasing direct ownership by 0.14% to 5,724 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/13/26 4:25:33 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kingsley Stuart A bought $29,953 worth of shares (940 units at $31.86), increasing direct ownership by 20% to 5,582 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 9:54:36 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLT
    $AVXL
    $CFB
    $DJT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Farrell Sarah E

    4 - Reddit, Inc. (0001713445) (Issuer)

    4/7/26 7:43:35 PM ET
    $RDDT
    EDP Services
    Technology

    SEC Form 4 filed by Seibel Michael

    4 - Reddit, Inc. (0001713445) (Issuer)

    4/7/26 7:43:12 PM ET
    $RDDT
    EDP Services
    Technology

    SEC Form 4 filed by Habiger David C

    4 - Reddit, Inc. (0001713445) (Issuer)

    4/7/26 7:42:40 PM ET
    $RDDT
    EDP Services
    Technology

    $APLT
    $AVXL
    $CFB
    $DJT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo resumed coverage on Reddit with a new price target

    Wells Fargo resumed coverage of Reddit with a rating of Equal Weight and set a new price target of $149.00

    4/7/26 8:11:14 AM ET
    $RDDT
    EDP Services
    Technology

    B. Riley Securities reiterated coverage on Reddit with a new price target

    B. Riley Securities reiterated coverage of Reddit with a rating of Buy and set a new price target of $250.00 from $245.00 previously

    2/6/26 8:27:21 AM ET
    $RDDT
    EDP Services
    Technology

    Evercore ISI initiated coverage on Reddit with a new price target

    Evercore ISI initiated coverage of Reddit with a rating of Outperform and set a new price target of $320.00

    1/13/26 9:17:42 AM ET
    $RDDT
    EDP Services
    Technology

    $APLT
    $AVXL
    $CFB
    $DJT
    Leadership Updates

    Live Leadership Updates

    View All

    Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Dr. Axel Paeger, MD, MBA, MBI to its Board of Directors. "We are delighted to welcome Dr. Paeger to our Board of Directors at Anavex," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. "Dr. Paeger brings three decades of strong leade

    2/23/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Wolfgang Liedtke, MD PhD, as Senior Vice President, Global Head of Neurology. Dr. Liedtke is a board-certified neurologist, who brings more than 25 years of extensive experience in developing and delivering innovative medicines in a broad range of CNS diseases, inclu

    1/8/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $APLT
    $AVXL
    $CFB
    $DJT
    Financials

    Live finance-specific insights

    View All

    Trump Media & Technology Group Reports Full-Year 2025 Results

    ~ $2.5 Billion in Financial Assets ~~ Positive Operating Cash Flow for 2025 ~~ $44 Million in Cash Proceeds from Options Strategy ~ SARASOTA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (NASDAQ:DJT) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the video streaming service Truth+, and the financial services and FinTech brand Truth.Fi, announced its financial results for the full year ending on December 31, 2025. These results are included in TMTG's Annual Report on Form 10-K that will be filed with the Securities and Exchange Commission (the "SEC") today. TMTG closed 2025 with financial assets of approximately $2.5 billio

    2/27/26 5:05:00 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

    Generated Record Quarterly and Full-Year Total SUBLOCADE® Net Revenue of $252 Million and $856 MillionAchieved Quarterly and Full-Year GAAP Net Income of $102 Million and $210 Million; Non-GAAP Quarterly and Full-Year Net Income of $107 Million and $320 MillionDelivered Record Quarterly and Full-Year Adjusted EBITDA of $142 Million and $428 MillionEntered Phase II of the Indivior Action Agenda – Accelerate – on January 1, 2026Authorized New $400 Million Share Repurchase ProgramReaffirmed Full-Year 2026 Financial Guidance Announced on January 8, 2026Conference Call at 8:00 A.M. EST Today RICHMOND, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today

    2/26/26 7:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

    Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported financial results for its first quarter of fiscal 2026. "As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer's disease

    2/9/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLT
    $AVXL
    $CFB
    $DJT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Funko Inc.

    SC 13G/A - Funko, Inc. (0001704711) (Subject)

    11/20/24 1:15:24 PM ET
    $FNKO
    Recreational Games/Products/Toys
    Consumer Discretionary

    SEC Form SC 13G filed by Indivior PLC

    SC 13G - INDIVIOR PLC (0001625297) (Subject)

    11/15/24 6:03:54 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Trump Media & Technology Group Corp.

    SC 13G/A - Trump Media & Technology Group Corp. (0001849635) (Subject)

    11/14/24 9:53:48 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology